AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
CA2740557C
(fr)
*
|
2008-10-17 |
2020-04-14 |
London Health Sciences Centre Research Inc. |
Annexine et son utilisation pour le traitement de troubles inflammatoires
|
US9585920B2
(en)
|
2011-02-04 |
2017-03-07 |
Katherine Rose Kovarik |
Method and system for treating cancer cachexia
|
US9457077B2
(en)
|
2009-11-18 |
2016-10-04 |
Katherine Rose Kovarik |
Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
|
WO2011151941A1
(fr)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
Composition présentant une activité d'induction de la prolifération ou de l'accumulation de cellule t régulatrice
|
US10842834B2
(en)
|
2016-01-06 |
2020-11-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
US11191665B2
(en)
|
2011-02-04 |
2021-12-07 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
US10314865B2
(en)
|
2011-02-04 |
2019-06-11 |
Katherine Rose Kovarik |
Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
|
US10512661B2
(en)
|
2011-02-04 |
2019-12-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
US10940169B2
(en)
|
2015-11-30 |
2021-03-09 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing cancer in an individual human being
|
US11419903B2
(en)
|
2015-11-30 |
2022-08-23 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
US10583033B2
(en)
|
2011-02-04 |
2020-03-10 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
US9730967B2
(en)
|
2011-02-04 |
2017-08-15 |
Katherine Rose Kovarik |
Method and system for treating cancer cachexia
|
US11273187B2
(en)
|
2015-11-30 |
2022-03-15 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing depression in an individual
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
EP3563682A1
(fr)
|
2011-08-08 |
2019-11-06 |
California Institute of Technology |
Utilité de nématodes à petites molécules
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
WO2013080561A1
(fr)
*
|
2011-12-01 |
2013-06-06 |
University Of Tokyo |
Bactéries d'origine humaine qui induisent la prolifération ou l'accumulation de lymphocytes t régulateurs
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
US10973861B2
(en)
|
2013-02-04 |
2021-04-13 |
Seres Therapeutics, Inc. |
Compositions and methods
|
EP2951285A4
(fr)
|
2013-02-04 |
2016-10-26 |
Seres Therapeutics Inc |
Compositions et procédés pour l'inhibition de croissance bactérienne pathogène
|
EP2967077A4
(fr)
|
2013-03-15 |
2016-09-14 |
Seres Therapeutics Inc |
Compositions microbiennes et procédés associés basés sur un réseau
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
WO2015025336A2
(fr)
*
|
2013-08-22 |
2015-02-26 |
Council Of Scientific & Industrial Research |
Composition probiotique comprenant la nouvelle souche bactérienne isolée de brevibacterium casei ap9
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
AU2014352643A1
(en)
|
2013-11-25 |
2016-06-30 |
Seres Therapeutics, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
US11026982B2
(en)
|
2015-11-30 |
2021-06-08 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
US11672835B2
(en)
|
2013-12-20 |
2023-06-13 |
Seed Health, Inc. |
Method for treating individuals having cancer and who are receiving cancer immunotherapy
|
US11529379B2
(en)
|
2013-12-20 |
2022-12-20 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
US11213552B2
(en)
|
2015-11-30 |
2022-01-04 |
Joseph E. Kovarik |
Method for treating an individual suffering from a chronic infectious disease and cancer
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
US11642382B2
(en)
|
2013-12-20 |
2023-05-09 |
Seed Health, Inc. |
Method for treating an individual suffering from bladder cancer
|
US10624934B2
(en)
|
2014-03-06 |
2020-04-21 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations
|
EP3113630B1
(fr)
*
|
2014-03-06 |
2019-12-11 |
The Research Institute at Nationwide Children's Hospital |
Préparations probiotiques et méthodes d'utilisation associées
|
EP2974735A1
(fr)
*
|
2014-07-15 |
2016-01-20 |
Institut National De La Recherche Agronomique (INRA) |
Propriétés anti-inflammatoires d'une protéine de surface de Propionibacterium freudenreichii
|
EP3209803A4
(fr)
|
2014-10-21 |
2018-06-13 |
Ubiome, Inc. |
Procédé et système de diagnostic et de thérapie fondés sur le microbiome
|
US10381112B2
(en)
|
2014-10-21 |
2019-08-13 |
uBiome, Inc. |
Method and system for characterizing allergy-related conditions associated with microorganisms
|
US11040049B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
GB2551642B
(en)
|
2014-10-31 |
2020-09-23 |
Pendulum Therapeutics Inc |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
JP6393425B2
(ja)
|
2014-12-08 |
2018-09-19 |
ジ アサン ファウンデーション |
バクテロイデス・アシジファシエンスを有効成分として含む、代謝性疾患の予防又は治療用薬学的組成物
|
US20160206666A1
(en)
*
|
2014-12-22 |
2016-07-21 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
|
SI3193901T1
(en)
|
2014-12-23 |
2018-06-29 |
4D Pharma Research Limited |
Pirin polypeptide and immune modulation
|
NO3065748T3
(fr)
|
2014-12-23 |
2018-04-21 |
|
|
US10383888B2
(en)
*
|
2015-04-10 |
2019-08-20 |
University Of Massachusetts |
Exopolysaccharide for inflammatory disease
|
ME03563B
(fr)
|
2015-06-15 |
2020-07-20 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
HUE044617T2
(hu)
|
2015-06-15 |
2019-11-28 |
4D Pharma Res Ltd |
Baktériumtörzseket tartalmazó készítmények
|
SG10201912324XA
(en)
|
2015-06-15 |
2020-02-27 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
KR101793328B1
(ko)
*
|
2015-07-03 |
2017-11-03 |
씨제이제일제당 (주) |
L-라이신 생산능을 갖는 미생물 및 이를 이용한 l-라이신 생산 방법
|
EP3322408B1
(fr)
|
2015-07-14 |
2022-06-08 |
The Research Institute at Nationwide Children's Hospital |
Nouvelle formulation pour l'élimination de pathogènes cariogènes et opportunistes dans la cavité buccale
|
KR20170032815A
(ko)
*
|
2015-09-15 |
2017-03-23 |
경희대학교 산학협력단 |
신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
|
WO2017066719A2
(fr)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Agents spécifiques interférant avec hu
|
US11685925B2
(en)
*
|
2015-10-30 |
2023-06-27 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
MD3209310T2
(ro)
|
2015-11-20 |
2018-06-30 |
4D Pharma Res Ltd |
Compoziții care conțin tulpini bacteriene
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
*
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
CN106852938A
(zh)
*
|
2015-12-09 |
2017-06-16 |
深圳华大基因研究院 |
拟杆菌(Bacteroides)在治疗和预防肥胖相关疾病中的应用
|
CA3010505A1
(fr)
|
2016-01-07 |
2017-07-13 |
Ascus Biosciences, Inc. |
Procedes pour ameliorer la production de lait par administration de consortiums microbiens
|
CN106974940B
(zh)
*
|
2016-01-15 |
2020-08-25 |
深圳华大生命科学研究院 |
厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用
|
CN107028985A
(zh)
*
|
2016-02-04 |
2017-08-11 |
深圳华大基因研究院 |
厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
|
GB2557823A
(en)
|
2016-03-04 |
2018-06-27 |
Univ California |
Microbial consortium and uses thereof
|
CN114712405A
(zh)
|
2016-03-04 |
2022-07-08 |
4D制药有限公司 |
包含细菌菌株的组合物
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
AU2017249159A1
(en)
|
2016-04-11 |
2018-11-29 |
President And Fellows Of Harvard College |
Probiotic formulations for improving athletic performance
|
WO2017181143A1
(fr)
|
2016-04-15 |
2017-10-19 |
Generon (Shanghai) Corporation, Ltd. |
Utilisation d'il-22 pour le traitement de l'entérocolite nécrosante
|
US10293005B2
(en)
|
2016-04-19 |
2019-05-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of gram negative species to treat atopic dermatitis
|
JP2019513769A
(ja)
|
2016-04-19 |
2019-05-30 |
ザ ユナイテッド ステイツ オブ アメリカ,アズ レプリゼンテッド バイ ザ セクレタリー,デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
アトピー性皮膚炎を処置するためのグラム陰性種の使用
|
WO2017184565A1
(fr)
|
2016-04-20 |
2017-10-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions et procédés d'expression d'acide nucléique et sécrétion de protéine dans des bactéroïdes
|
US10188709B2
(en)
*
|
2016-04-25 |
2019-01-29 |
University Of The Sciences |
Compositions and methods for the treatment of phenylketonuria (PKU)
|
CN105943577B
(zh)
*
|
2016-04-29 |
2018-02-13 |
刘东波 |
植物药的微生物发酵
|
PL3452050T3
(pl)
|
2016-05-05 |
2023-06-12 |
Glycom A/S |
Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
|
JP2019520340A
(ja)
*
|
2016-06-01 |
2019-07-18 |
クレストヴォ・ホールディングス・エルエルシー |
炎症性腸疾患(ibd)および他の障害を治療するための組成物および方法
|
JP6774664B2
(ja)
*
|
2016-06-14 |
2020-10-28 |
コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジーKorea Research Institute Of Bioscience And Biotechnology |
退行性脳疾患の予防又は治療効果を有するアガトバキュラム属菌株及びその用途
|
US9999641B2
(en)
|
2016-06-14 |
2018-06-19 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
FI3468573T3
(fi)
*
|
2016-06-14 |
2023-10-02 |
Vedanta Biosciences Inc |
Clostridium difficile -infektion hoito
|
WO2017223273A1
(fr)
*
|
2016-06-22 |
2017-12-28 |
President And Fellows Of Harvard College |
Inhibition de cellules lymphoïdes innées de groupe 3 du côlon
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
EP3490602A4
(fr)
*
|
2016-08-01 |
2020-03-25 |
Scaled Microbiomics, LLC |
Systèmes et procédés de modification du microbiome pour réduire le risque de maladie et les manifestations de la maladie
|
JP7097027B2
(ja)
*
|
2016-08-10 |
2022-07-07 |
モナッシュ ユニバーシティ |
自己免疫疾患の処置及び予防のための代謝物
|
WO2018039593A1
(fr)
|
2016-08-25 |
2018-03-01 |
California Institute Of Technology |
Traitement par ascaroside de l'oesophagite à éosinophiles
|
US20180185421A1
(en)
*
|
2016-08-29 |
2018-07-05 |
Tokyo Metropolitan Government |
Composition comprising fecal microbiota
|
WO2018045493A1
(fr)
*
|
2016-09-06 |
2018-03-15 |
深圳华大基因研究院 |
Christensenella intestinihominis et son application
|
US10428370B2
(en)
|
2016-09-15 |
2019-10-01 |
Sun Genomics, Inc. |
Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample
|
US11959125B2
(en)
|
2016-09-15 |
2024-04-16 |
Sun Genomics, Inc. |
Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample
|
WO2018075886A1
(fr)
*
|
2016-10-21 |
2018-04-26 |
The University Of Chicago |
Compositions et procédés permettant d'induire une préservation du système immunitaire, afin de prévenir et/ou traiter des infections
|
US20190269740A1
(en)
*
|
2016-10-26 |
2019-09-05 |
Nutech Ventures |
Use of probiotic bacterial strains and cell extracts to inhibit acidosis and liver abscesses in cattle
|
KR101938865B1
(ko)
*
|
2016-11-03 |
2019-01-16 |
주식회사 쎌바이오텍 |
골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
|
EP3541400A2
(fr)
*
|
2016-11-18 |
2019-09-25 |
Sanford Burnham Prebys Medical Discovery Institute |
Microbiote intestinal et traitement du cancer
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
WO2018112437A1
(fr)
*
|
2016-12-15 |
2018-06-21 |
uBiome, Inc. |
Procédé et système pour caractériser des affections liées à une allergie et associées à des micro-organismes
|
WO2018112194A1
(fr)
|
2016-12-15 |
2018-06-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions et procédés pour moduler la croissance d'une cellule bactérienne intestinale génétiquement modifiée
|
WO2018109018A1
(fr)
|
2016-12-16 |
2018-06-21 |
Nestle Skin Health Sa |
Capsule comprenant un microorganisme probiotique pour utilisation dans un dispositif de production et de distribution de compositions
|
US11129858B2
(en)
|
2016-12-20 |
2021-09-28 |
The Regents Of The University Of California |
Compositions and methods for inhibiting seizures
|
CN110582291A
(zh)
*
|
2016-12-22 |
2019-12-17 |
古斯达威罗斯研究所 |
抗pd1/pd-l1/pd-l2抗体的反应性标志物和功效改善用调节剂
|
US11179426B2
(en)
|
2016-12-29 |
2021-11-23 |
Kibow Biotech, Inc. |
Composition and method for maintaining healthy kidney function
|
EP3565533A4
(fr)
|
2017-01-05 |
2021-02-17 |
The University of Chicago |
Inhibition d'infection entérique par l'intermédiaire de la modulation de microbiote
|
EP3572087B9
(fr)
*
|
2017-01-23 |
2023-10-04 |
Cupione Co., Ltd. |
Composition destinée à la prévention ou au traitement de l'arthrose contenant comme principe actif du sialyllactose ou un sel correspondant
|
FR3062063B1
(fr)
*
|
2017-01-26 |
2019-04-19 |
Centre National De La Recherche Scientifique |
Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
|
US10596206B1
(en)
|
2017-03-14 |
2020-03-24 |
Cornell University |
Probiotic compositions and methods of use
|
US10733214B2
(en)
*
|
2017-03-20 |
2020-08-04 |
International Business Machines Corporation |
Analyzing metagenomics data
|
EP3378949A1
(fr)
*
|
2017-03-22 |
2018-09-26 |
Assistance Publique - Hôpitaux de Paris |
Procédé pour déterminer l'efficacité potentielle d'un traitement anticancéreux
|
CN107189956B
(zh)
*
|
2017-03-30 |
2020-11-10 |
深圳大学 |
一种肝素酶高产菌株及其选育方法
|
WO2018187272A1
(fr)
|
2017-04-03 |
2018-10-11 |
Gusto Global, Llc |
Conception rationnelle d'agents biothérapeutiques d'origine microbienne
|
US20200054697A1
(en)
*
|
2017-04-17 |
2020-02-20 |
Baylor College Of Medicine |
Commensal bacteria as novel treatment for dry eye and sjogren syndrome
|
US20200188476A1
(en)
*
|
2017-04-18 |
2020-06-18 |
The Regents Of The University Of California |
Anti-microbial agent-polymer conjugates and methods of use thereof
|
CN110913702A
(zh)
|
2017-04-28 |
2020-03-24 |
埃斯库斯生物科技股份公司 |
利用微生物的人造生物集合在反刍动物中用于支持谷物加强剂和/或能量加强剂饮食的方法
|
WO2018204757A1
(fr)
*
|
2017-05-04 |
2018-11-08 |
Second Genome, Inc. |
Protéines pour le traitement de troubles de la fonction barrière épithéliale
|
WO2018213262A1
(fr)
*
|
2017-05-19 |
2018-11-22 |
Memorial Sloan-Kettering Cancer Center |
Procédés et compositions pour réduire une infection ou une colonisation par listeria monocytogenes
|
EP3630137B1
(fr)
*
|
2017-05-22 |
2023-05-17 |
4D Pharma Research Limited |
Compositions comprenant des souches bactériennes
|
MA41708A
(fr)
|
2017-05-24 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
WO2018218211A1
(fr)
*
|
2017-05-26 |
2018-11-29 |
Animal Microbiome Analytics, Inc. |
Produits et procédés d'administration thérapeutique de micro-organismes à des animaux non humains
|
US11174293B2
(en)
|
2017-06-02 |
2021-11-16 |
Second Genome, Inc. |
Proteins for the treatment of epithelial barrier function disorders
|
US11638728B2
(en)
|
2017-06-05 |
2023-05-02 |
The University Of Chicago |
Microbiome biomarkers immunotherapy responsiveness: diagnostic, prognostic and therapeutic uses thereof
|
PL3600364T3
(pl)
*
|
2017-06-14 |
2021-01-11 |
4D Pharma Research Limited |
Kompozycje zawierające szczep bakteryjny z rodzaju megasphaera i ich zastosowania
|
SI3638271T1
(sl)
|
2017-06-14 |
2021-01-29 |
4D Pharma Research Limited |
Sestavki, ki vsebujejo bakterijske seve
|
AR112328A1
(es)
*
|
2017-07-05 |
2019-10-16 |
Evelo Biosciences Inc |
Composiciones y métodos para tratamiento de cáncer usando bifidobacterium animalis ssp. lactis
|
CA3069567A1
(fr)
|
2017-07-18 |
2019-01-24 |
Keio University |
Composition antibacterienne contre les bacteries induisant les cellules th1
|
EP3661525A4
(fr)
*
|
2017-08-04 |
2020-07-22 |
Second Genome, Inc. |
Roseburia hominis, eubacterium eligens et combinaisons de celles-ci en tant qu'agents biothérapeutiques
|
US11865145B2
(en)
|
2017-08-07 |
2024-01-09 |
Finch Therapeutics Holdings Llc |
Compositions and methods for maintaining and restoring a healthy gut barrier
|
WO2019032572A1
(fr)
*
|
2017-08-07 |
2019-02-14 |
Finch Therapeutics, Inc. |
Compositions et procédés de décolonisation de bactéries résistantes aux antibiotiques dans l'intestin
|
RU2020110462A
(ru)
|
2017-08-14 |
2021-09-16 |
Серес Терапеутикс, Инк. |
Композиции и способы для лечения холестатического заболевания
|
KR101978565B1
(ko)
*
|
2017-08-14 |
2019-05-15 |
경희대학교 산학협력단 |
루미노코커스 브로미 유래 풀루란 분해 효소 및 이의 용도
|
TWI640314B
(zh)
*
|
2017-08-22 |
2018-11-11 |
長庚生物科技股份有限公司 |
戈氏副擬桿菌用於降低胰島素抗性及提升葡萄糖耐受性之用途
|
US20200197448A1
(en)
*
|
2017-08-29 |
2020-06-25 |
Bgi Shenzhen |
Application of Alistipes shahii in preparing a composition for preventing and/or treating lipid metabolism related diseases
|
WO2019046646A1
(fr)
|
2017-08-30 |
2019-03-07 |
Whole Biome Inc. |
Methodes et compositions pour le traitement de troubles associés au microbiome
|
WO2019046372A1
(fr)
*
|
2017-08-31 |
2019-03-07 |
The Regents Of The University Of Michigan |
Compositions et procédés permettant d'augmenter la production de butyrate
|
MX2020002659A
(es)
|
2017-09-08 |
2020-09-09 |
Evelo Biosciences Inc |
Vesiculas extracelulares bacterianas.
|
CN111601610A
(zh)
*
|
2017-11-14 |
2020-08-28 |
伊夫罗生物科学公司 |
使用布劳特氏菌属菌株治疗疾病的组合物和方法
|
WO2019113023A1
(fr)
*
|
2017-12-04 |
2019-06-13 |
The BioCollective, LLC |
Probiotiques et procédés d'utilisation
|
US20200405775A1
(en)
*
|
2017-12-11 |
2020-12-31 |
Vedanta Biosciences, Inc |
Compositions and methods for suppressing pathogenic organisms
|
EP3723775A4
(fr)
*
|
2017-12-15 |
2022-04-13 |
Solarea Bio, Inc. |
Compositions microbiennes et méthodes de traitement du diabète de type 2, de l'obésité et du syndrome métabolique
|
PL423964A1
(pl)
*
|
2017-12-19 |
2019-07-01 |
Izabela Anna Zawisza |
Kompozycja bakterii probiotycznych, zastosowanie kompozycji bakterii probiotycznych oraz sposób personalizowana kompozycji bakterii probiotycznych
|
WO2019136391A1
(fr)
*
|
2018-01-05 |
2019-07-11 |
Human Longevity, Inc. |
Compositions probiotiques comprenant des bactéries provenant de bacteroïdes et firmicutes phyla
|
KR20200136365A
(ko)
*
|
2018-01-05 |
2020-12-07 |
누비요타 엘엘씨 |
공동선택 미생물총을 포함하는 조성물 및 그 이용 방법
|
CN111712260A
(zh)
*
|
2018-01-31 |
2020-09-25 |
伊夫罗生物科学公司 |
使用毛螺菌科细菌治疗免疫病症的组合物和方法
|
WO2019157003A1
(fr)
*
|
2018-02-06 |
2019-08-15 |
Evelo Biosciences, Inc. |
Compositions et méthodes pour traiter le cancer et des troubles immunitaires au moyen de bacteries veillonelles
|
EP3750548A4
(fr)
*
|
2018-02-09 |
2021-10-20 |
Noster Inc. |
Bactéries entériques régulées par des lipopolysaccharides et leur utilisation
|
US20220186292A1
(en)
*
|
2018-02-20 |
2022-06-16 |
Md Healthcare Inc. |
Nano-vesicle derived from catenibacterium bacteria and use thereof
|
WO2019169160A1
(fr)
*
|
2018-02-28 |
2019-09-06 |
Evelo Biosciences, Inc. |
Compositions et méthodes de traitement du cancer à l'aide de ruminococcus gnavus
|
WO2019169168A1
(fr)
*
|
2018-02-28 |
2019-09-06 |
Evelo Biosciences, Inc. |
Compositions et méthodes de traitement du cancer à l'aide d'agathobaculum
|
WO2019178490A1
(fr)
*
|
2018-03-15 |
2019-09-19 |
Evelo Biosciences, Inc. |
Compositions et procédés pour traiter le cancer et l'inflammation utilisant klebsiella oxytoca
|
BR112020018564A2
(pt)
*
|
2018-03-15 |
2020-12-29 |
University Of Southern California |
Composição probiótica para doença gastrointestinal autoimune e/ou inflamatória, uso de uma dieta que simula jejum para prevenir ou tratar doença gastrointestinal autoimune e/ou inflamatória, e suplemento dietário
|
US20210038654A1
(en)
*
|
2018-03-16 |
2021-02-11 |
Persephone Biosciences |
Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same
|
WO2019191073A1
(fr)
*
|
2018-03-28 |
2019-10-03 |
Trustees Of Dartmouth College |
Modification du microbiome intestinal dans la fibrose kystique
|
US20210121505A1
(en)
*
|
2018-03-29 |
2021-04-29 |
Seres Therapeutics, Inc. |
Compositions and methods for treating inflammatory bowel diseases
|
EP3773645A4
(fr)
|
2018-04-10 |
2021-11-24 |
Siolta Therapeutics, Inc. |
Consortia microbiens
|
CA3097607A1
(fr)
*
|
2018-04-18 |
2019-10-24 |
Forte Subsidiary, Inc. |
Compositions pour le traitement d'affections cutanees
|
US11918611B2
(en)
*
|
2018-05-03 |
2024-03-05 |
Crigasseni Ag |
Probiotic bacterial strains producing antimicrobial proteins and compositions comprising these for use in the treatment of diarrheal and other microbial diseases
|
JP2021523895A
(ja)
|
2018-05-11 |
2021-09-09 |
フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited |
細菌株を含む組成物
|
US10973841B2
(en)
|
2018-05-11 |
2021-04-13 |
Forte Subsidiary, Inc. |
Compositions for the treatment of skin conditions
|
CA3101184A1
(fr)
*
|
2018-05-24 |
2019-11-28 |
Seres Therapeutics, Inc. |
Compositions bacteriennes specifiques et leurs utilisations
|
US10456430B1
(en)
*
|
2018-05-25 |
2019-10-29 |
Genmont Biotech Incorporation |
Lactobacillus composition for prevention and treatment of bacterial vaginosis
|
KR20210016391A
(ko)
*
|
2018-05-31 |
2021-02-15 |
킴벌리-클라크 월드와이드, 인크. |
건강한 피부 미생물총을 유지하기 위한 프리바이오틱 조성물 및 방법
|
JP7126004B2
(ja)
*
|
2018-05-31 |
2022-08-25 |
ビージーアイ シェンチェン |
組成物及びその使用
|
US11541105B2
(en)
|
2018-06-01 |
2023-01-03 |
The Research Foundation For The State University Of New York |
Compositions and methods for disrupting biofilm formation and maintenance
|
CN116004439A
(zh)
*
|
2018-06-06 |
2023-04-25 |
艾姆瓦克香港有限公司 |
产生吡啶二羧酸的微生物聚生体和选择与运载体共配制的微生物的方法
|
JP2021526526A
(ja)
*
|
2018-06-14 |
2021-10-07 |
フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited |
細菌株を含む組成物
|
AU2019285353A1
(en)
*
|
2018-06-14 |
2021-01-07 |
Ajinomoto Co., Inc. |
Compound comprising substance having affinity for antibody, cleavage site and reactive group, or salt thereof
|
CN109001455B
(zh)
*
|
2018-06-15 |
2021-09-10 |
天津一瑞生物科技股份有限公司 |
一种肺泡灌洗液样本处理液及处理检测方法
|
US20190388344A1
(en)
*
|
2018-06-22 |
2019-12-26 |
Probiotech Llc |
Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor
|
WO2020005995A2
(fr)
*
|
2018-06-25 |
2020-01-02 |
Kawana Shoko |
Anaerostipes hadrus utilisé pour promouvoir la santé
|
FR3083545A1
(fr)
|
2018-07-04 |
2020-01-10 |
Institut National De La Recherche Agronomique |
Utilisation d'une souche de roseburia intestinalis pour la prevention et le traitement de l'inflammation de l'intestin
|
SG11202013008UA
(en)
*
|
2018-07-10 |
2021-02-25 |
Univ Keio |
Intestinal microbe having d-psicose-responsive proliferation
|
JP2021533150A
(ja)
*
|
2018-08-05 |
2021-12-02 |
ダ・ヴォルテッラ |
移植片対宿主病の治療のための組成物
|
WO2020033708A1
(fr)
*
|
2018-08-08 |
2020-02-13 |
Mars, Incorporated |
Produits alimentaires pour animaux de compagnie comprenant des oligosaccharides et procédés d'utilisation
|
CN109350629B
(zh)
*
|
2018-08-09 |
2021-06-01 |
新乡医学院 |
一种用于治疗酒精戒断综合征的益生菌复合制剂及其制备方法
|
KR20210091119A
(ko)
*
|
2018-08-17 |
2021-07-21 |
베단타 바이오사이언시즈, 인크. |
장내세균 불균형을 감소시키는 방법 및 마이크로바이옴을 회복시키는 방법
|
TW202023590A
(zh)
*
|
2018-08-17 |
2020-07-01 |
英商4D製藥研究有限公司 |
包含細菌菌株之組合物
|
KR20200021257A
(ko)
*
|
2018-08-20 |
2020-02-28 |
아주대학교산학협력단 |
유박테리움 렉탈레를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
|
US11980647B2
(en)
|
2018-09-05 |
2024-05-14 |
Solarea Bio, Inc. |
Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
|
CA3111795A1
(fr)
|
2018-09-05 |
2020-03-12 |
Solarea Bio, Inc. |
Methodes et compositions pour le traitement de maladie musculo-squelettiques
|
WO2020056298A1
(fr)
*
|
2018-09-13 |
2020-03-19 |
Assembly Biosciences, Inc. |
Procédés et compositions pour traiter des troubles gastro-intestinaux et inflammatoires
|
TW202023589A
(zh)
*
|
2018-09-20 |
2020-07-01 |
英商4D製藥研究有限公司 |
包含細菌品系之組成物
|
KR102135195B1
(ko)
*
|
2018-10-08 |
2020-07-17 |
아주대학교산학협력단 |
테트라제노코커스 할로필러스를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
|
MX2021004150A
(es)
*
|
2018-10-09 |
2021-06-08 |
4D Pharma Res Limited |
Composiciones que comprenden cepas bacterianas.
|
WO2020079021A1
(fr)
|
2018-10-15 |
2020-04-23 |
Pharmabiome Ag |
Consortiums de bactéries vivantes utiles pour le traitement de maladies associées au cancer, en particulier de la maladie du greffon contre l'hôte
|
CN109273046B
(zh)
*
|
2018-10-19 |
2022-04-22 |
江苏东南证据科学研究院有限公司 |
一种基于概率统计模型的生物学全同胞鉴定方法
|
EP3866822A1
(fr)
*
|
2018-10-19 |
2021-08-25 |
4D Pharma Research Limited |
Compositions comprenant des souches bactériennes
|
SG11202104224SA
(en)
*
|
2018-10-26 |
2021-05-28 |
Sun Genomics Inc |
Universal method for extracting nucleic acid molecules from a diverse population of microbes
|
JP2022512813A
(ja)
*
|
2018-11-02 |
2022-02-07 |
フォーディー ファーマ リサーチ リミテッド |
細菌株を含む組成物
|
CN109486739B
(zh)
*
|
2018-11-23 |
2022-02-01 |
上海海洋大学 |
一种诱导副溶血性弧菌产生左氧氟沙星耐药性的方法
|
WO2020107073A1
(fr)
*
|
2018-11-28 |
2020-06-04 |
The Council Of The Queensland Institute Of Medical Research |
Inhibition d'inflammation
|
MA54161A
(fr)
|
2018-12-12 |
2022-03-23 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes parabacteroides pour le traitement du cancer
|
CN109364096A
(zh)
*
|
2018-12-25 |
2019-02-22 |
浙江华康药业股份有限公司 |
一种木糖醇肠溶片及其制备方法和应用
|
CN109528777A
(zh)
*
|
2018-12-25 |
2019-03-29 |
东北农业大学 |
由鼠李糖乳杆菌和2`-岩藻糖基乳糖组成的组合物的应用
|
CN111410973B
(zh)
*
|
2019-01-08 |
2021-05-04 |
湖南农业大学 |
一种调控生物炭形貌结构的方法
|
CN111408343B
(zh)
*
|
2019-01-08 |
2022-01-28 |
湖南农业大学 |
三维立体生物炭的制备方法及其在重金属吸附中的应用
|
KR102285335B1
(ko)
*
|
2019-02-14 |
2021-08-04 |
주식회사 엠디헬스케어 |
로치아 속 세균 유래 나노소포 및 이의 용도
|
CN110055188A
(zh)
*
|
2019-03-07 |
2019-07-26 |
南京师范大学 |
一株产抑菌肽的多粘类芽孢杆菌xw4及其分离筛选和应用
|
CN109757731A
(zh)
*
|
2019-03-14 |
2019-05-17 |
广州普维君健药业有限公司 |
缓解乳糖不耐的益生菌组合物及其制备方法和应用
|
CN109749993B
(zh)
*
|
2019-03-28 |
2022-07-05 |
众合天诚细胞生物科技(吉林)有限公司 |
一种脐带间充质干细胞的培养方法
|
IL265735A
(en)
*
|
2019-03-31 |
2019-05-30 |
Biomica |
A microbial consortium and its uses
|
CN110060739B
(zh)
*
|
2019-04-26 |
2021-08-31 |
扬州大学 |
一种水禽pcm遗传多样性评价方法
|
US11884958B2
(en)
|
2019-04-30 |
2024-01-30 |
Mayo Foundation For Medical Education And Research |
Assessing and treating functional gastrointestinal disorders
|
EP3965804A4
(fr)
*
|
2019-05-06 |
2023-05-24 |
Synthetic Biologics, Inc. |
Compositions de bêta-lactamase pour le traitement de la maladie du greffon contre l'hôte
|
EP3917550B1
(fr)
*
|
2019-05-10 |
2024-01-24 |
CJ Bioscience, Inc. |
Compositions comprenant des blautia hydrogenotrophica dans le traitement de fibromyalgie
|
EP3969460A4
(fr)
|
2019-05-17 |
2023-03-08 |
California Institute Of Technology |
Dérivés d'ascaroside et procédés d'utilisation
|
US20220248644A1
(en)
*
|
2019-05-24 |
2022-08-11 |
Superbrewed Food, Inc. |
Method and composition for improving health of an avian
|
US20220409650A1
(en)
*
|
2019-06-03 |
2022-12-29 |
Holoclara, Inc. |
Compositions and methods for ascaroside modification of mammalian microbiota
|
WO2021010937A1
(fr)
*
|
2019-07-17 |
2021-01-21 |
Emmaus Medical, Inc. |
Procédés et compositions pour le traitement de la drépanocytose et de la thalassémie
|
EP3999084A4
(fr)
*
|
2019-07-19 |
2023-07-12 |
Finch Therapeutics Holdings LLC |
Methodes et produits pour le traitement de troubles gastro-intestinaux
|
WO2021016081A1
(fr)
*
|
2019-07-19 |
2021-01-28 |
Finch Therapeutics Holdings Llc. |
Méthodes et produits destinés au traitement de troubles gastro-intestinaux
|
EP4006552A2
(fr)
*
|
2019-07-30 |
2022-06-01 |
Kobiolabs, Inc. |
Kit pour prédire ou diagnostiquer une stéatose hépatique non alcoolique et procédé pour diagnostiquer une stéatose hépatique
|
CN112415156A
(zh)
*
|
2019-08-22 |
2021-02-26 |
华北制药集团新药研究开发有限责任公司 |
一种阿尼芬净原料药细菌内毒素的检测方法
|
CN112438995A
(zh)
|
2019-09-04 |
2021-03-05 |
台达电子工业股份有限公司 |
抑制具万古霉素抗药性肠球菌的益生菌及其组合与其用途
|
CN110564643B
(zh)
*
|
2019-09-16 |
2021-07-09 |
泰安大凡神农生物有限公司 |
一株具有促骨髓间充质干细胞增殖作用的动物双歧杆菌及其应用
|
WO2021059241A1
(fr)
*
|
2019-09-27 |
2021-04-01 |
The University Of British Columbia |
Compositions de microbiome et méthodes de traitement d'atopies
|
WO2021071864A1
(fr)
|
2019-10-07 |
2021-04-15 |
Siolta Therapeutics, Inc. |
Compositions pharmaceutiques thérapeutiques
|
CN114828642A
(zh)
*
|
2019-10-21 |
2022-07-29 |
杜邦营养生物科学有限公司 |
用于消化道健康的组合物
|
US20210128643A1
(en)
*
|
2019-10-30 |
2021-05-06 |
Seah H. Lim |
Micro-organismal product and method for treating sickle cell disease
|
BR112022010174A2
(pt)
*
|
2019-11-25 |
2022-08-09 |
Fitbiomics Inc |
Composições para aperfeiçoamento do desempenho atlético e métodos de uso das mesmas
|
JPWO2021106952A1
(fr)
*
|
2019-11-26 |
2021-06-03 |
|
|
CA3159711A1
(fr)
*
|
2019-11-27 |
2021-06-03 |
Asuncion Martinez |
Compositions bacteriennes et leurs utilisations
|
WO2021119291A1
(fr)
*
|
2019-12-10 |
2021-06-17 |
Northeastern University |
Compositions microbiennes et procédés de traitement et de détection de maladies
|
CN110946913B
(zh)
*
|
2019-12-17 |
2021-01-19 |
河北一然生物科技有限公司 |
缓解便秘及痔疮的益生菌组合物
|
WO2021141828A1
(fr)
*
|
2020-01-10 |
2021-07-15 |
Assembly Biosciences, Inc. |
Compositions comprenant des espèces bactériennes et procédés associés
|
WO2021154954A1
(fr)
*
|
2020-01-29 |
2021-08-05 |
Etheim Biotics, Llc |
Compositions et procédés pour traiter des biofilms, des infections et des parodontites
|
EP4106779A4
(fr)
*
|
2020-02-18 |
2024-03-20 |
Memorial Sloan Kettering Cancer Center |
Méthodes et compositions pour identifier et traiter les sujets susceptibles de présenter le risque d'une faible survie à un cancer
|
US20230084309A1
(en)
*
|
2020-02-19 |
2023-03-16 |
Evive Biotechnology (Shanghai) Ltd |
Methods for treating graft versus host disease
|
CN111304120B
(zh)
*
|
2020-02-24 |
2021-07-23 |
浙江大学 |
Blautia sp B2132菌在预防和/或治疗炎症性肠病中的应用
|
CN111363671B
(zh)
*
|
2020-02-26 |
2023-07-21 |
天津医科大学 |
一种肠道厌氧微生物培养瓶及其制备方法
|
CN111398582B
(zh)
*
|
2020-03-02 |
2022-06-14 |
浙江海洋大学 |
海鲜产品检测试剂盒及其制备方法
|
KR102162470B1
(ko)
*
|
2020-03-19 |
2020-10-06 |
주식회사 비피도 |
비피도박테리움 슈도카테눌라튬 c-rapo (kctc13986bp), 비피도박테리움 비피덤 att (kctc13474bp) 균주를 포함하는 쇼그렌증후군 억제용 식품 조성물 및 약학 조성물
|
US20230149477A1
(en)
*
|
2020-04-07 |
2023-05-18 |
The National Institute for Biotechnology in the Negev Ltd. |
Methods of improving health of young ruminants
|
EP3895716A1
(fr)
*
|
2020-04-17 |
2021-10-20 |
Maat Pharma |
Test de prédiction de performance fmt pour guider et optimiser la gestion thérapeutique de patients atteints d'une réaction du greffon contre l'hôte (gvhd)
|
CN111560330B
(zh)
*
|
2020-05-12 |
2022-04-26 |
天津科技大学 |
一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用
|
KR102167386B1
(ko)
*
|
2020-05-14 |
2020-10-19 |
코스맥스 주식회사 |
피부 장벽 강화, 피부 보습 또는 항노화를 위한 조성물
|
US20230201276A1
(en)
*
|
2020-05-21 |
2023-06-29 |
Superbrewed Food, Inc. |
Method of treating or preventing an infection
|
US20230248777A1
(en)
*
|
2020-05-29 |
2023-08-10 |
Figene, Llc |
Augmentation of fibroblast cell therapy efficacy by microbiome manipulation
|
CN111743998A
(zh)
*
|
2020-06-04 |
2020-10-09 |
中通美雅生命健康(深圳)有限公司 |
用于辅助治疗肠炎组合物及其制备方法
|
WO2021252632A2
(fr)
*
|
2020-06-09 |
2021-12-16 |
Flagship Pioneering, Inc. |
Compositions physiologiquement acceptables contenant des micro-organismes ou des produits microbiens
|
JP2023530671A
(ja)
*
|
2020-06-10 |
2023-07-19 |
ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー |
ブタの健康及び発育成績を向上させるブタ由来のプロバイオティクス
|
CN111560376B
(zh)
*
|
2020-06-15 |
2022-03-25 |
浙江大学 |
一种特异抑制OLFM4基因表达的siRNA及其应用
|
EP4164390A4
(fr)
*
|
2020-06-16 |
2024-05-29 |
Dsm Ip Assets Bv |
Composition servant à réduire le risque d'infection des voies urinaires et d'infection vaginale chez les femmes
|
KR102169794B1
(ko)
*
|
2020-06-24 |
2020-10-27 |
주식회사 엔테로바이옴 |
신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도
|
CN113197311B
(zh)
*
|
2020-07-03 |
2023-06-23 |
内蒙古蒙牛乳业(集团)股份有限公司 |
一种乳酸菌组合物及其制备方法
|
EP4180051A1
(fr)
*
|
2020-07-13 |
2023-05-17 |
Ajou University Industry-Academic Cooperation Foundation |
Composition pour la prévention ou le traitement d'une affection intestinale inflammatoire
|
WO2022023458A1
(fr)
*
|
2020-07-31 |
2022-02-03 |
Pharmabiome Ag |
Cartographie de niche microbienne
|
US20230293599A1
(en)
*
|
2020-08-03 |
2023-09-21 |
Universiteit Gent |
Bacterial compositions with anti-inflammatory activity
|
CN112143747B
(zh)
*
|
2020-09-09 |
2022-09-13 |
昆明理工大学 |
一种噬菌体裂解酶及其基因、基因重组表达载体与应用
|
US20230321276A1
(en)
*
|
2020-09-30 |
2023-10-12 |
Alma Bio Therapeutics |
Nucleic acid therapy for differential modulation of host microflora
|
CN112322528B
(zh)
*
|
2020-11-03 |
2022-07-22 |
江南大学 |
一株可干预代谢综合征的鼠李糖乳杆菌及应用
|
CN112262918A
(zh)
*
|
2020-11-18 |
2021-01-26 |
内蒙古自治区农牧业科学院 |
一种饲用微生态菌剂悬浮剂及其制备方法
|
CN112375712A
(zh)
*
|
2020-11-25 |
2021-02-19 |
昆明理工大学 |
一株乳酸乳球菌及其应用
|
KR102269962B1
(ko)
*
|
2020-12-11 |
2021-06-28 |
주식회사 바이오뱅크힐링 |
유박테리움 리모숨 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
|
KR102296290B1
(ko)
*
|
2020-12-31 |
2021-09-01 |
주식회사 바이오뱅크힐링 |
비피도박테리움 아돌레센티스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
|
KR102269966B1
(ko)
*
|
2021-01-12 |
2021-06-28 |
주식회사 바이오뱅크힐링 |
루미노코쿠스 파에시스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
|
US20240082294A1
(en)
*
|
2021-01-06 |
2024-03-14 |
Florida Atlantic University Board Of Trustees |
Cancer treatment regimen using anti-parasitic compounds and gut microbiome modulating agents
|
CN112574929B
(zh)
*
|
2021-01-11 |
2022-06-07 |
吉林大学 |
一株吉林类芽孢杆菌ypg26及其医用用途
|
JP2024506052A
(ja)
*
|
2021-02-08 |
2024-02-08 |
リスキュア・バイオサイエンシーズ・カンパニー・リミテッド |
ロイコノストック・シトレウム菌株を有効成分として含む胆汁うっ滞性肝疾患の予防または治療用医薬組成物
|
US20240148738A1
(en)
*
|
2021-03-05 |
2024-05-09 |
Dsm Ip Assets B.V. |
Method of increasing the population of blautia spp. in the gut microbiome
|
WO2022232661A1
(fr)
*
|
2021-04-29 |
2022-11-03 |
Evolve Biosystems, Inc. |
Immunothérapie personnalisée faisant appel à des métabolites intestinaux
|
CN113081987B
(zh)
*
|
2021-04-29 |
2022-03-25 |
药大制药有限公司 |
一种氟胞嘧啶片剂及其制备方法
|
AU2022284272A1
(en)
*
|
2021-06-01 |
2023-12-07 |
International N&H Denmark Aps |
Bacterial strains for use in preventing, treating and/or reducing symptoms associated with a rhinovirus-induced cold infection
|
CN113337444A
(zh)
*
|
2021-06-26 |
2021-09-03 |
北京大学深圳研究院 |
一株弯曲芽孢杆菌及其产pha的应用
|
EP4362961A1
(fr)
*
|
2021-06-28 |
2024-05-08 |
Vedanta Biosciences, Inc. |
Procédés de colonisation par un microbiome, de traitement et/ou de prévention d'une maladie intestinale inflammatoire et d'une maladie du greffon contre l'hôte
|
US20230034247A1
(en)
*
|
2021-07-06 |
2023-02-02 |
Agency For Science, Technology And Research |
Method and composition for treating or decreasing gut microbiome dysbiosis induced by a prior antibiotic treatment
|
AU2022312473A1
(en)
*
|
2021-07-10 |
2024-02-29 |
Microba Ip Pty Ltd |
Compositions and methods for treating disease ii
|
EP4376880A1
(fr)
*
|
2021-07-28 |
2024-06-05 |
The Texas A&M University System |
Compositions de vaccin comprenant des souches de brucella et leurs procédés
|
KR102351146B1
(ko)
*
|
2021-08-02 |
2022-01-14 |
주식회사 바이오뱅크힐링 |
페디오코쿠스 에시디락티시 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
|
KR102331485B1
(ko)
*
|
2021-08-02 |
2021-12-01 |
주식회사 바이오뱅크힐링 |
블라우티아 웩슬러래 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
|
CN113444673B
(zh)
*
|
2021-08-17 |
2022-06-07 |
河南省科学院生物研究所有限责任公司 |
一株戈氏红球菌yksw-6及其应用
|
WO2023064443A1
(fr)
*
|
2021-10-13 |
2023-04-20 |
Cornell University |
Compositions antimicrobiennes
|
WO2023069655A1
(fr)
*
|
2021-10-20 |
2023-04-27 |
City Of Hope |
Compositions de clostridium butyricum et leurs méthodes d'utilisation
|
CN113718047B
(zh)
*
|
2021-11-04 |
2022-02-18 |
艾德范思(北京)医学检验实验室有限公司 |
荧光定量方法检测人母乳内10属细菌的试剂盒及其应用
|
WO2023086620A1
(fr)
*
|
2021-11-12 |
2023-05-19 |
Gelesis, Llc |
Compositions et procédés pour moduler le microbiome intestinal
|
WO2023092150A1
(fr)
|
2021-11-22 |
2023-05-25 |
Solarea Bio, Inc. |
Méthodes et compositions pour le traitement de maladies musculo-squelettiques, le traitement d'une inflammation et la prise en charge de symptômes de la ménopause
|
CN113929221B
(zh)
*
|
2021-11-22 |
2023-07-14 |
宁波大学 |
一种用于处理水产养殖尾水的微生物复合菌群
|
WO2023114356A2
(fr)
*
|
2021-12-16 |
2023-06-22 |
Alveolus Bio, Inc. |
Agents biothérapeutiques inhalables séchés par pulvérisation pour le traitement d'une maladie
|
WO2023140657A1
(fr)
*
|
2022-01-20 |
2023-07-27 |
가톨릭대학교 산학협력단 |
Analyse de la flore intestinale chez des patients greffés du foie, surveillance ainsi de l'état de transplantation, et composition de théranostic immunomodulatrice
|
CN114470154B
(zh)
*
|
2022-01-27 |
2023-11-07 |
华南理工大学 |
一种甜杏仁油糖蛋白酚酸纳米肠道益生菌促进剂及其制备和应用
|
WO2023161315A1
(fr)
*
|
2022-02-23 |
2023-08-31 |
Société des Produits Nestlé S.A. |
Compositions et procédés pour réduire l'apparition de diarrhée en favorisant blautia obeum dans le microbiote intestinal
|
BE1030385B1
(fr)
*
|
2022-03-24 |
2023-10-23 |
Bellavie |
Capsules à usage par voie orale comprenant une formulation à base de probiotiques, conditionnées en dose unitaire dans un emballage-coque stratifié
|
CN114848662B
(zh)
*
|
2022-04-12 |
2023-06-27 |
亿药科技(苏州)有限公司 |
纳他霉素在制备预防和/或治疗非酒精性脂肪性肝病或肝炎药物中的应用
|
CN114854778B
(zh)
*
|
2022-04-15 |
2023-05-30 |
青岛农业大学 |
一种岩藻多糖酶基因Fcn1及其应用
|
WO2023225667A2
(fr)
*
|
2022-05-20 |
2023-11-23 |
Synlogic Operating Company, Inc. |
Bactéries recombinantes pour la production d'acide indole-3-acétique (aia) et leurs utilisations
|
CN115109718B
(zh)
*
|
2022-05-25 |
2023-09-12 |
中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) |
一株屎肠球菌菌株及其用途
|
CN114854884A
(zh)
*
|
2022-05-27 |
2022-08-05 |
山东农业大学 |
用属水平的粪便微生物预警或无创诊断脂肪肝奶牛的方法
|
CN115852001A
(zh)
*
|
2022-11-23 |
2023-03-28 |
深圳海关动植物检验检疫技术中心 |
一种小麦病原菌检测方法及其应用
|